iCopyDAV: Integrated platform for copy number variations—Detection, annotation and visualization P Dharanipragada, S Vogeti, N Parekh PLoS One 13 (4), e0195334, 2018 | 54 | 2018 |
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH KL Hung, J Luebeck, SR Dehkordi, CI Colón, R Li, ITL Wong, C Coruh, ... Nature genetics 54 (11), 1746-1754, 2022 | 51 | 2022 |
Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges K Song, JK Minami, A Huang, SR Dehkordi, SH Lomeli, J Luebeck, ... Cancer discovery 12 (4), 1046-1069, 2022 | 39 | 2022 |
Blocking genomic instability prevents acquired resistance to MAPK inhibitor therapy in melanoma P Dharanipragada, X Zhang, S Liu, SH Lomeli, A Hong, Y Wang, Z Yang, ... Cancer discovery 13 (4), 880-909, 2023 | 24 | 2023 |
Multi-organ landscape of therapy-resistant melanoma S Liu, P Dharanipragada, SH Lomeli, Y Wang, X Zhang, Z Yang, RJ Lim, ... Nature medicine 29 (5), 1123-1134, 2023 | 8 | 2023 |
SeqVItA: Sequence variant identification and annotation platform for next generation sequencing data P Dharanipragada, SR Seelam, N Parekh Frontiers in Genetics 9, 413951, 2018 | 6 | 2018 |
Genome-wide characterization of copy number variations in diffuse large B-cell lymphoma with implications in targeted therapy P Dharanipragada, N Parekh Precision Clinical Medicine 2 (4), 246-258, 2019 | 5 | 2019 |
Copy number variation detection workflow using next generation sequencing data P Dharanipragada, N Parekh 2016 International Conference on Bioinformatics and Systems Biology (Bsb), 1-5, 2016 | 4 | 2016 |
Abstract LB251: Blocking genomic instability delays acquired resistance to MAPK inhibitor therapy in melanoma P Dharanipragada, X Zhang, S Liu, SH Lomeli, A Hong, Y Wang, Z Yang, ... Cancer Research 83 (8_Supplement), LB251-LB251, 2023 | | 2023 |
In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines P Dharanipragada, N Parekh Cells 12 (4), 596, 2023 | | 2023 |
Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy K Manna, P Dharanipragada, D Alkam, NL Avaritt, CL Washam, ... bioRxiv, 2022.02. 15.480454, 2022 | | 2022 |
Detection and Functional Characterization of Genetic Variations in Diffuse Large B cell Lymphoma P Dharanipragada International Institute of Information Technology, Hyderabad, 2020 | | 2020 |
Identifying Biomarkers for Diffuse Large B-Cell Lymphoma Subtypes P Dharanipragada, N Parekh Novel Approaches in Cancer Study 3 (2), 260-262, 2019 | | 2019 |